
Lyora Therapeutics launches with $2.5M seed funding to develop genetic medicines for inherited retinal diseases.
Lyora Therapeutics, a biotech startup, has launched with $2.5 million in seed funding to develop genetic medicines targeting inherited retinal diseases that currently lack treatments. Their lead programs, LYA-101 and LYA-102, aim to treat retinitis p...


